The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
J. Clin. Invest. Aimin Xu, et al. 112:91 doi:10.1172/JCI17797 [Go to this article.]

Figure 3
Adiponectin treatment ameliorates alcohol-induced dyslipidemia and hepatic abnormality in mice. Serum samples were collected after 5 weeks of LC diet, LE diet, or LE + Ad diet in the last 2 weeks. Serum levels of TG (a) and FFA (b), liver-to-body weight ratio (c), hepatic TG contents (d), and plasma ALT levels (e) were determined at necropsy (n = 5). ^#P < 0.05, ^##P < 0.01 for LC-treated mice versus LE-treated mice; *P < 0.05, **P < 0.01 for LE + Ad–treated mice versus LE-treated mice.